A3 Adenosine Receptor Ligands For Modulation Of Pigmentation

Abstract

The present invention relates to compositions and methods for modulating melanin production, secretion and/or accumulation in human skin cells. In particular, the present invention relates to the use of A3 adenosine receptor antagonists in compositions and methods for the treatment and amelioration of hyper-pigmentation conditions and for the lightening of skin, and to the use of A3 adenosine receptor agonists in compositions and methods for the treatment and amelioration of hypo-pigmentation conditions and for the tanning of skin.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jun 6, 2017
  • Application: Nov 13, 2015
    US US 201514941108 A
  • Priority: Nov 13, 2015
    US US 201514941108 A
  • Priority: Jan 20, 2012
    US US 201213386339 A
  • Priority: Jul 20, 2010
    IL IL 2010000576 W
  • Priority: Jul 21, 2009
    US US 22707909 P

Sign in to the Lens

Feedback